A new anticancer drug capable of "lysing" cancer cells has been granted approval to enter clinical trials in China, the drug's developers said Wednesday. The drug, jointly developed by Xiamen University and two Chinese companies。
From November 11 to 17, President Zhang Rong led a delegation to visit Japan and Singapore to promote exchanges and cooperation with partner universities and colleges. During the visit, they held the Overseas Young Scholar Forum and met alumni of Xiamen University (XMU).
2018-12-14 20:27:02
2018-12-14 20:27:02
2018-12-08 20:38:28
2018-12-08 20:38:28
2018-10-13 21:45:43
2018-10-13 21:45:43
2018-06-23 21:42:56
2018-06-23 21:42:56
2018-06-09 09:45:37
2018-06-09 09:45:37
